组织因子在肿瘤病理中的作用研究进展
摘要
组织因子不仅在凝血途径中发挥重要作用，还参与了胚胎形成、炎症、信号传导、细胞迁移和肿瘤生长等病理生理过程。目前组织因子在肿瘤中的作用日益受到重视。本文对近年来组织因子在肿瘤病理中的作用研究进展进行综述。
出处
《国际输血及血液学杂志》
CAS
2011年第2期171-174,共4页
International Journal of Blood Transfusion and Hematology
基金
基金项目：国家自然科学基金资助项目（30801062）
参考文献31
-
1Mackman N. Alternatively spliced tissue factor one cut too many? Thromb Haemost, 2007, 97(1): 5-8.
-
2Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor= a circulating, soluble, thrombogenic protein. Nat Med, 2003, 9(4):458-462.
-
3Bogdanov VY, Kirk RI, Miller C, et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost,2006, 4(1) :158-167.
-
4Signaevsky M, Hobbs J, Doll J, et al. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost, 2008, 34(2) :161-169.
-
5Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol,2007, 27(8) : 1687-1693.
-
6Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol,2006, 26(12): 2594-2604.
-
7Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cell. J Thromb Haemost,2004, 2(11):2065-2067.
-
8Falanga A. Thrombosis and malignancy: An underestimated problem. Haematologica,2003, 88(6) :607-610.
-
9Khorana AA, Ahrendt SA, Ryan CK, et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res,2007, 13(10):2870-2875.
-
10Uno K, Homma S, Satoh T, et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer,2007, 96(2) :290-295.
-
1杨玉清.2001—2005年1209例恶性肿瘤病理资料分析[J].山西医药杂志,2006,35(7):621-621.
-
2李钧.华法令对心房颤动121例抗凝疗效分析[J].中国保健营养（临床医学学刊）,2009,18(3):75-76.
-
3王骏,王鸣和,严铭玉,周贇,张雁,孙育民,唐琦,胡雷光,陈坚.急性心肌梗死患者血浆纤维蛋白原与C反应蛋白水平相关性研究[J].世界临床药物,2007,28(5):266-268. 被引量：3
-
4全国交界性肿瘤病理及诊断病理研讨会[J].中华医学信息导报,1999,0(22):9-9.
-
5Adrie C.,Monchi M.,Laurent I.,张平.心脏骤停成功心肺复苏后的凝血异常:蛋白C抗凝血途径的意义[J].世界核心医学期刊文摘（心脏病学分册）,2005,0(11):47-47. 被引量：1
-
6李玉来(综述),路青(综述),许建荣(审校).磁共振淋巴管（结）造影剂应用的新进展[J].实用放射学杂志,2011,27(7):1109-1112. 被引量：2
-
7冯津萍,赵炳让.组织因子途径抑制物与冠心病[J].中国循环杂志,2004,19(1):72-74. 被引量：1
-
8王蕊,徐从高,温丙昭.凝血因子的变化与心脑血管疾病相关性[J].血栓与止血学,2006,12(1):34-36. 被引量：2
-
9济宁医学院附属医院专家简介[J].山东医药,2008,48(6).
-
10宋琪,张一梅.血小板组织因子的研究进展[J].实用医学杂志,2012,28(4):671-673.
